Lactoferrin

乳铁蛋白

Report date: 2026/03/31 20:00:21

Base Information

Drug NameLactoferrin
Drug Alias NameGPX 400hLFGPX-400
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pain, PostoperativeNeonatal Sepsis +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyEgypt
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsPain, PostoperativeVaginosis, Bacterial
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Neonatal Sepsis

Other Information

ATC CodeN/A
Related LinksN/A